Press Release: Noveome : Noveome Biotherapeutics, Inc. Receives FDA Notification to Proceed with its Phase 1-2 Clinical Trial in Treatment of NEC

In connection with the FDA notification, Noveome anticipates a closing on at least an additional $13.5 million of Series E convertible preferred stock financing PITTSBURGH, PA, UNITED STATES, December 11, 2023 /⁨EINPresswire.com⁩/ -- Noveome ...